PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
78.41
ESG score exceeding 1.2x SGMO's 60.06. Mohnish Pabrai would examine if this ESG advantage creates sustainable competitive moats.
78.54
Environmental score exceeding 1.2x SGMO's 53.73. Mohnish Pabrai would examine if this environmental advantage creates sustainable cost advantages.
90.14
Social score exceeding 1.2x SGMO's 62.40. Mohnish Pabrai would examine if this social advantage creates sustainable talent and customer acquisition advantages.
66.56
Similar governance score to SGMO's 64.05. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.